Synthesis of 4,4-disubstituted-4H-benzo[d][1,3]oxathiin-2-ones, a new class of compounds

Synthetic Communications

Volumn 36, Issue 10, 2006, Pages 1419-1429

  Kamila, Sukanta ^a   Khan, Omair ^a   Zhang, Hongming ^a   Biehl, Edward R ^a  

^a SOUTHERN METHODIST UNIVERSITY   (United States)

Author keywords

CDI; Cyclization; Grignard reagent; Oxathiin 2 one; PR antagonist

Indexed keywords

4,4 BIS (2,3 DIMETHYLPHENYL) 4H BENZO[D][1,3]OXATHIIN 2 ONE; 4,4 BIS (3,4 DIMETHOXYPHENYL) 4H BENZO[D][1,3]OXATHIIN 2 ONE; 4,4 BIS (4 METHOXYPHENYL) 4H BENZO[D][1,3]OXATHIIN 2 ONE; 4,4 DIETHYL 4H BENZO[D][1,3]OXATHIIN 2 ONE; 4,4 DIISOPROPYL 4H BENZO[D][1,3]OXATHIIN 2 ONE; 4,4 DIMETHYL 4H BENZO[D][1,3]OXATHIIN 2 ONE; 4,4 DIPHENYL 4H BENZO[D][1,3]OXATHIIN 2 ONE; ANTIGESTAGEN; METHANOL DERIVATIVE; OXATHIIN DERIVATIVE; PROGESTERONE RECEPTOR; REAGENT; THIOSALICYLIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CYCLIZATION; GRIGNARD REACTION;

EID: 33645575115     PISSN: 00397911     EISSN: 15322432     Source Type: Journal    
DOI: 10.1080/00397910500522140     Document Type: Article

References (14)

1. Mangelsdorf, D. J.; Thummel, C.; Beato, M.; Herrlich, P.; Schutz, G.; Umesono, K.; Blumberg, B.; Kastner, P.; Mark, M.; Chambon, P.; Evans, R. M. The nuclear receptor superfamily: The second decade. Cell 1995, 83, 835-839.
2. Tabata, Y.; Iizuka, Y.; Kashiwa, J.; Masuda, N. T.; Shinei, R.; Kurihara, K.; Okonogi, T.; Hoshiko, S.; Kurata, Y. Fungal metabolities, PF 1092 compounds and their derivatives, are nonsteroidal and selective progesterone receptor modulators. Eur. J. Pharmacol. 2001, 430, 159-165.
3. Palmer, S.; Campen, C. A.; Allan, G. F.; Rybczynski, P.; Haynes-Johnson, D.; Hutchins, A.; Kraft, P.; Kiddoe, M.; Lai, M.-T.; Lombardi, E.; Pedersen, P.; Hodgen, G.; Combs, D. W. Nonsteriodal progesterone receptor ligands with unprecedented receptor ligands with unprecedented receptor selectivity. J. Steriod Biochem. Mol. Biol. 2001, 75, 33-42.
4. Hamann, L. G.; Winn, D. T.; Pooley, C. L.F.; Tegley, C. M.; West, S. J.; Farmer, L. J.; Zhi, L.; Edwards, J. P.; Marschke, K. B.; Mais, D. E.; Goldman, M. E.; Jones, T. K. Nonsteroidal progesterone receptor antagonists based on a conformationally restricted subseries of 6-aryl-1,2-dihydro-2,2,4- trimethylquinolines. Bioorg. Med. Chem. Lett. 1998, 8, 2731-2736.
5. Zhi, L.; Tegley, C. M.; Pio, B.; West, S. J.; MarSchke, K. B.; Mais, D. E.; Jones, T. K. Nonsteroidal progesterone receptor antagonists based on 6-thiophenylhydroquinolines. Bioorg. Med. Chem. Lett. 2000, 10, 415-418.
6. Hamann, L. G.; Farmer, L. J.; Johson, M. G.; Bender, S. L.; Mais, D. E.; Wang, M.-W.; Crombie, D.; Goldman, M. E.; Jones, T. K. Synthesis and biological activity of novel nonsteroidal progesterone receptors antagonists based on cyclocymopol monomethyl ether. J. Med. Chem. 1996, 39, 1778-1789.
7. Pooley, C. L. F.; Edwards, J. P.; Goldman, M. E.; Wang, M.-W.; Marschke, K. B.; Crombie, D. L.; Jones, T. K. Discovery and preliminary SAR studies of a novel, nonsteroidal progesterone receptor antagonist pharmacophore. J. Med. Chem. 1996, 41, 3461-3466.
8. Zhang, P.; Terefenko, E. A.; Wrobel, J.; Zhang, Z.; Zhu, Y.; Cohen, J.; Marschke, K. B.; Mais, D. Synthesis and progesterone receptor antagonist activities of 6-aryl benzimidazolones and benzothiazolones. Bioorg. Med. Chem. Lett. 2001, 11, 2747-2750.
9. Zhang, P.; Terefenko, E. A.; Fensome, A.; Zhang, Z.; Zhu, Y.; Cohen, J.; Winneker, R.; Wrobel, J.; Yardley, J. Potent nonsteroidal progesterone receptor agonists: Synthesis and SAR study of 6-aryl benzoxazines. Bioorg. Med. Chem. Lett. 2002, 12, 787-790.
10. Zhang, P.; Terefenko, E. A.; Fensome, A.; Wrobel, J.; Winneker, R.; Lundeen, S.; Marschke, K. B.; Zhang, Z. 6-Aryl-1,4-dihydro-benzo[d][1,3]oxazin- 2-ones: A novel class of potent, selective, and orally active nonstereodal pogesterone receptor antagonists. J. Med. Chem. 2002, 45, 4379-4382.
11. Fuhrmann, U.; Hess-Stump, H.; Cleve, A.; Neef, G.; Schwede, W.; Hoffmann, J.; FritzeMeir, K.-H.; Chwalisz, K. Synthesis and biological activity of a novel, highly potent progesterone receptor antagonist. J. Med. Chem. 2000, 43, 5010-5016.
12. Kloosterboer, H. J.; Deckers, G. H.; de Gooyer, M. E.; Dijkema, R.; Orlemans, E. O. M.; Schoonen, W. G. E. J. Pharmacological properties of a new selective antiprogestagen: Org 33628. Ann. N. Y. Acad. Sci. 1995, 761, 192-201.
13. Kloosterboer, H. J.; Deckers, G. H.; Schoonen, W. G. E. J.; Hanssen, R. G. J. M.; Rose, U. M.; Verbost, P. M.; Hsiu, J. G.; Williams, R. F.; Hodgen, G. D. Preclinical experience with two selective progesterone receptor modulators on breast and endometrium. Steriods 2000, 65, 733-740.
14. Seio, K.; Kumura, K.; Bologna, J. C.; Sekine, M. Enhanced stereoselectivity in internucleotide bond formation by the use of the chiral ribose moiety of thymidine. J. Org. Chem. 2003, 68, 3849-3859.